Atlas Trials

Phase 1/2 Study to Determine Optimal Dose for Treating Bone Metastases Using Novel STAT-RT Workflow

Clinical trial NCT02145286 · UNKNOWN

Trial details

NCT number
NCT02145286
Sponsor
Paul W. Read, MD
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Bone Lesion
Start date
2013-10-01
Primary completion
2019-01-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.